Investors’ deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approvals and M&A.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Compass ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where Xeris ...

We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...

A Durham biotechnology company has seen its stock price plummet over the past few days amid a stock offering and a media ...

AbbVie, Danaher, Thermo Fisher Scientific, Cognizant Technology Solutions, Vertex Pharmaceuticals, Alnylam Pharmaceuticals, ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 3 undervalued ...

The ASX 200 biotech stock notes that HIE is a devastating type of brain injury caused when a baby's brain does not receive ...

JP Morgan sees strong growth for Ascentage Pharma, citing its late-stage cancer drugs. The biotech's 2024 sales surged 342% ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...